T. Logan

A phase 2, randomized study of SB‐485232, rhIL‐18, in patients with previously untreated metastatic melanoma

Ahmad A. Tarhini, Michael Millward, Paul N. Mainwaring et al. · Cancer · 2009 · 120 citations

Exploratory analysis of the influence of nephrectomy status on temsirolimus efficacy in patients with advanced renal cell carcinoma and poor-risk features

T. Logan, David F. McDermott, J. P. Dutcher et al. · Journal of Clinical Oncology · 2008 · 37 citations

Surgical Oncology, Renal Pathology, Temsirolimus Efficacy +18

Phase II trial of ipilimumab monotherapy in melanoma patients with brain metastases.

Donald P. Lawrence, Omid Hamid, David F. McDermott et al. · Journal of Clinical Oncology · 2010 · 29 citations

Neuro-oncology, Oncology, Phase Ii Trial +15

Randomized comparison of tamoxifen versus diethylstilbestrol in estrogen receptor-positive or -unknown metastatic breast cancer: a Southeastern Cancer Study Group trial.

Gockerman Jp, Spremulli En, M Raney et al. · PubMed · 1986 · 28 citations

Breast Oncology, Cancer Management, Gynecology +17

Talimogene laherparepvec (T-VEC) in combination (combo) with ipilimumab (ipi) versus ipi alone for advanced melanoma: 3-year landmark analysis of a randomized, open-label, phase II trial

Jason Chesney, Igor Puzanov, Frances A. Collichio et al. · Annals of Oncology · 2019 · 10 citations · Full text

Medicine, Melanoma, 3-Year Landmark Analysis +11